Lipid Nanoparticle Gene Coding With SalioGen Therapeutics’ Ray Tabibiazar, M.D. In The News / By walid
An Interview with Ray Tabibiazar, M.D., CEO & Chairman of SalioGen Therapeutics In The News / By walid
PharmaShots Interview: SalioGen Therapeutics’ Ray Tabibiazar Shares Insights on Gene Coding Platform In The News / By walid
VCs plow $115M into next-gen genetic medicine startup SalioGen, teeing up work on eye and liver diseases In The News / By walid
Gene therapy 3.0 efforts net SalioGen a nine-figure Series B, but much remains under wraps In The News / By walid
